<?xml version='1.0' encoding='utf-8'?>
<document id="25829948"><sentence text="Mining severe drug-drug interaction adverse events using Semantic Web technologies: a case study." /><sentence text="Drug-drug interactions (DDIs) are a major contributing factor for unexpected adverse drug events (ADEs)" /><sentence text=" However, few of knowledge resources cover the severity information of ADEs that is critical for prioritizing the medical need" /><sentence text=" The objective of the study is to develop and evaluate a Semantic Web-based approach for mining severe DDI-induced ADEs" /><sentence text="" /><sentence text="We utilized a normalized FDA Adverse Event Report System (AERS) dataset and performed a case study of three frequently prescribed cardiovascular drugs: Warfarin, Clopidogrel and Simvastatin"><entity charOffset="152-160" id="DDI-PubMed.25829948.s6.e0" text="Warfarin" /><entity charOffset="162-173" id="DDI-PubMed.25829948.s6.e1" text="Clopidogrel" /><entity charOffset="178-189" id="DDI-PubMed.25829948.s6.e2" text="Simvastatin" /><pair ddi="false" e1="DDI-PubMed.25829948.s6.e0" e2="DDI-PubMed.25829948.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25829948.s6.e0" e2="DDI-PubMed.25829948.s6.e1" /><pair ddi="false" e1="DDI-PubMed.25829948.s6.e0" e2="DDI-PubMed.25829948.s6.e2" /><pair ddi="false" e1="DDI-PubMed.25829948.s6.e1" e2="DDI-PubMed.25829948.s6.e1" /><pair ddi="false" e1="DDI-PubMed.25829948.s6.e1" e2="DDI-PubMed.25829948.s6.e2" /></sentence><sentence text=" We extracted putative DDI-ADE pairs and their associated outcome codes" /><sentence text=" We developed a pipeline to filter the associations using ADE datasets from SIDER and PharmGKB" /><sentence text=" We also performed a signal enrichment using electronic medical records (EMR) data" /><sentence text=" We leveraged the Common Terminology Criteria for Adverse Event (CTCAE) grading system and classified the DDI-induced ADEs into the CTCAE in the Web Ontology Language (OWL)" /><sentence text="" /><sentence text="We identified 601 DDI-ADE pairs for the three drugs using the filtering pipeline, of which 61 pairs are in Grade 5, 56 pairs in Grade 4 and 484 pairs in Grade 3" /><sentence text=" Among 601 pairs, the signals of 59 DDI-ADE pairs were identified from the EMR data" /><sentence text="" /><sentence text="The approach developed could be generalized to detect the signals of putative severe ADEs induced by DDIs in other drug domains and would be useful for supporting translational and pharmacovigilance study of severe ADEs" /><sentence text="" /></document>